Elizabeth R. Madichie

Elizabeth Madichie serves as the Executive Vice President of Global Regulatory Affairs, Quality, Safety & Market Access at Veristat since April 2023. Previously, Elizabeth held leadership roles at TOPRA, including Past President and Board Director, as well as President and Chair of the Board from January 2021 to December 2023. Elizabeth's extensive experience in regulatory affairs includes directorships at Porton Biopharma Ltd and PPD, where roles spanned from Vice President & Global Head of Regulatory Affairs to Senior Director positions. Additionally, Elizabeth has contributed to the regulatory landscape as a Global Regulatory Affairs Consultant and has held various roles at Taro Pharmaceuticals, Elan, and GlaxoSmithKline. An academic background in analytical chemistry includes a PhD, MSc, and BSc(Hons) from the University of Hull.